Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Explore a curated set of 5 Hedge Funds articles, from Tepper's AI bets to Ackman's AI moves, showing how big bets can influence risk, diversification, and portfolio growth.
77 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Prentice Capital has exited its Compass position, reporting a zero stake after the latest quarter. This move highligh...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
A big-name hedge fund recently disclosed a fresh stake in a leading utility company, adding roughly 1.9 million share...
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
Discover how Marek Capital's co-founder approaches credit, risk, and portfolio design. This practical, investor-focus...
Hightower’s active bets in Netflix, Target, and Broadcom surface as Nvidia prepares to unveil new AI developments at ...
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
A hedge fund famous for bold bets shows a striking concentration: nearly half of its $14 billion stock portfolio sits...
In quarterly 13F disclosures, billionaire loeb sold shares of major AI players while adding to a smaller AI stock tha...
When a leading shipping stock leaps by a double-digit percentage, traders watch closely for what's driving the gains....
A hedge fund just trimmed a large stake in NCR Voyix, but does that spell change for ordinary investors? This guide b...